SARS-CoV-2 Neutralizing Antibodies in White-Tailed Deer from Texas
Author(s) -
Pedro M. Palermo,
Jeanette Orbegozo,
Douglas M. Watts,
John C. Morrill
Publication year - 2021
Publication title -
vector-borne and zoonotic diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.839
H-Index - 73
eISSN - 1557-7759
pISSN - 1530-3667
DOI - 10.1089/vbz.2021.0094
Subject(s) - seroprevalence , serology , antibody , neutralization , virology , biology , white (mutation) , covid-19 , veterinary medicine , medicine , virus , immunology , infectious disease (medical specialty) , biochemistry , disease , gene
Serological evidence of SARS-CoV-2 infection among white-tailed deer has been reported from Illinois, Michigan, Pennsylvania, and New York. This study was conducted to determine whether deer in Texas also had evidence of SARS-CoV-2 infection. Archived sera samples collected from deer in Travis County, Texas, during 2018, before and during the pandemic in 2021 were tested for neutralizing antibody to this virus by a standard plaque reduction neutralization assay. SARS-CoV-2 antibody was not detected in 40 deer sera samples collected during 2018, but 37% (20/54) samples collected in 2021 were positive for antibody. The seroprevalence rate between males and females differed significantly ( p < 0.05) and the highest rate (82%) was detected in the 1.5-year-old animals. These findings extended the geographical range of prior SARS-CoV-2 infection among white-tailed deer in the United States and further confirm that infection was common among this species.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom